Acetylsalicylic acid tablets 75 mg;Lisinopril 10 mg tablets;Bisoprolol tablets of 5 mg;Spironolactone tablets/capsules 25 mg each;Omeprazole 20 mg capsules;Amlodipine 5 mg tablets;Quetiapine, film-coated tablets, 25 mg each;Chlorhexidine, solution for external use 0.05% per 100 ml;Diclofenac solution for injection 25 mg/ml;Ringer's solution for infusions of 200 ml;Cyanocobalamin (vitamin B12), solution for injection, 0.5 mg/ml, 1 ml each
By: Gennady Grishin📍 UkraineClosed
Key Information
| Reference | GB-UA-2026-11-06-001954-a |
|---|
| Deadline | Nov 12, 2026 12:00 AM |
|---|
| Estimated Value | UAH 2,972,477.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 21010, Ukraine, Vinnytsia region, Vinnytsia, 1st Botanichnyi lane, bldg.38 |
|---|
| Published | Nov 6, 2026 |
|---|
Description
Acetylsalicylic acid tablets 75 mg;Lisinopril 10 mg tablets;Bisoprolol tablets of 5 mg;Spironolactone tablets/capsules 25 mg each;Omeprazole 20 mg capsules;Amlodipine 5 mg tablets;Quetiapine, film-coa...
Full details are available after unlocking this tender.